Innovation Pharmaceuticals Inc (IPIX)

[centillion]

Of course not, they own it!

Remdesivir wouldn't be described as bleak by Gilead or its shareholders.

This is who I'm referring too!

Only a COVID patient would describe it that way.

The money that is, or will be, raked in is a byproduct of an FDA EUA approved therapeutic drug that has no immediate threat toward it's usage, because at the moment there isn't any other approved EUA therapeutic drug(s) as competition, with one exception, a steroid being dispersed to counter against the inflammation issues that arise from being infected with Covid-19. All to the best of my knowledge of course!